362 patents currently held
218 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
13 more records may belong here and await a decision; they are not counted.
The next term ends in Dec 2026. from the record
Of the 218 now held by other companies, 49 name Scholl S Wellness Company LLC as their current owner, and 169 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
21
Ending by 2030
Dec 2026
Next term end
296
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Oct 2034 · High confidence
Also notable
Ends Oct 2036 · High confidence
Also notable
Ends Sep 2029 · Low confidence
Self-Orienting Syringe and Syringe Interface
US 9,173,995
The most cited patent in this portfolio, cited by 115 later US patents, top 5% of utility patents granted in 2015 in our data. Protection runs to 2034.
System and Method for Syringe Fluid Fill Verification and Image Recognition of Power Injector System Features
US 10,420,902
Cited by 74 later US patents, top 5% of utility patents granted in 2019 in our data. Protection runs to 2036.
Inserter
US 10,561,524
Cited by 17 later US patents, top 25% of utility patents granted in 2020 in our data. Protection runs to 2029. A terminal disclaimer caps this term to an earlier patent's.
Formerly held, still cited
Notable
Ends Dec 2027 · High confidence
The most cited patent in this portfolio, cited by 237 later US patents, top 5% of utility patents granted in 2010 in our data. Protection runs to 2027.
now held by Boston Scientific Medical Device Limited
Also notable
Ends Sep 2028 · High confidence
Cited by 51 later US patents, top 25% of utility patents granted in 2011 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2028.
now held by Ascensia Diabetes Care Holdings AG
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 3 fees due Nov 21 to 30, 2026 · next Nov 21
- 3 fees due Dec 6 to 13, 2026 · next Dec 6
- 4 fees due Jan 4 to 18, 2027 · next Jan 4
- 6 fees due Feb 1 to 28, 2027 · next Feb 1
- 2 fees due Mar 19 to 24, 2027 · next Mar 19
- 4 fees due Apr 3 to 17, 2027 · next Apr 3
- 6 fees due May 3 to 28, 2027 · next May 3
- 6 fees due Jun 1 to 24, 2027 · next Jun 1
- 4 fees due Jul 9 to 30, 2027 · next Jul 9
- 9 fees due Aug 4 to 27, 2027 · next Aug 4
- 11 fees due Sep 5 to 29, 2027 · next Sep 5
- 6 fees due Oct 2 to 30, 2027 · next Oct 2
- 2 fees due Nov 7, 2027
Recent changes
- Nov 6Assignment recorded on 1 record: Turan, Sören, DR. and 2 others to Bayer Aktiengesellschaft Recorded Nov 6, 2026, executed Nov 3, 2026. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76664, frame 255.
- Oct 29Assignment recorded on 1 record: Bennemann, Helmut, DR. and 4 others to Bayer Aktiengesellschaft Recorded Oct 29, 2026, executed Oct 15, 2026. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76556, frame 752.
- 15 of the patents on this record were granted since Aug 16, 2026
- 14 terms have ended since Aug 16, 2026
What they patent
The 5 largest of its 296 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Monitoring of Products | 5 in force | to Mar 2039 |
| Self-Orienting Syringe and Syringe Interface | 5 in force | to Sep 2036 |
| Inserter | 5 in force | to Sep 2029 |
| System and Method for Syringe Fluid Fill Verification and Image Recognition of Power Injector System Features (2016) | 4 in force | to Sep 2037 |
| System and Method for Syringe Fluid Fill Verification and Image Recognition of Power Injector System Features (2016) | 4 in force | to Apr 2037 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,475,701 | Valve Systems and Injector System Including Such Valve Systems held by Bayer Healthcare LLC In force · High confidence | In force | High confidence | |
| US 11,628,088 | Ultrasonically Detectable Intrauterine System and a Method for Enhancing Ultrasound Detection In force · High confidence | In force | High confidence | |
| US 8,961,491 | Catheters and Related Equipment held by Bayer Healthcare LLC In force · Medium confidence | In force | Medium confidence | |
| US 8,096,316 | Valve Systems for Use with a Fluid Injector System held by Bayer Healthcare LLC In force · High confidence | In force | High confidence | |
| US 7,976,867 | Dermal, Transdermal, Mucosal or Transmucosal Ingredient Delivery Devices held by Bayer Healthcare LLC In force · High confidence | In force | High confidence | |
| US 8,877,933 | Thermodynamically Stable Form of a Tosylate Salt held by Bayer Healthcare LLC In force · High confidence | In force | High confidence | |
| US 8,124,782 | Process for the Preparation of 4-{4-[({[4-Chloro-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-Carboxamide held by Bayer Healthcare LLC In force · High confidence | In force | High confidence | |
| US 9,008,759 | Devices and Systems for Determination of Parameters for a Procedure, for Estimation of Cardiopulmonary Function and for Fluid Delivery held by Bayer Healthcare LLC In force · Low confidence | In force | Low confidence | |
| US 8,939,940 | Blow-Molded Syringe for Use with Injectors held by Bayer Healthcare LLC In force · Medium confidence | In force | Medium confidence | |
| US 9,095,653 | Method For The Timed Dosage Of Medicaments In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 362: 218 patents in force now held by others · 1,590 patents ended · 421 applications pending · 1,246 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.